CMMI has spent more than a decade learning which organizations consistently deliver high-value care. The next step is to let ...

Community health workers are uniquely suited to help underresourced communities navigate structural barriers and mitigate the ...

Weeks earlier, the New York City Council passed the Guaranteeing Unbiased AI Regulation and Disclosure (GUARD) Act, which ...

The surge in vaccine litigation is not simply a post-pandemic, temporary issue. It is a deeper erosion of the legal principles that have long supported public health authority.

As with so many core functions of public health, the future success of vaccine promotion research depends on the support of every institution: government, universities, and industry alike.

CMS and states should look beyond simply expanding disclosure and improving standardization to also elevate antitrust safeguards.

William D. J. Roberts, MBA, MSc is a Commonwealth Fund Harkness Fellow and a Research Fellow at both the Harvard T.H. Chan School of Public Health and Brown ...

The emergence of Lilly’s bundling strategy for Zepbound and Taltz reflects the unregulated state of patient assistance programs in the commercial market and the need for Congressional intervention.

Before ChatGPT Health becomes a default destination for people seeking to make sense of their health, we need better evidence ...

In postacute care, we have built a quality architecture that treats falls as actionable events and functional decline as expected aging. The resulting safety-without-recovery trade-off is not a ...

For decades, mpox did not pose a threat to Americans, but that changed rapidly and repeatedly over the past five years.

This article examines the PBM-related provisions in the 2026 Consolidated Appropriations Act in the context of other federal and state efforts to regulate PBMs, then offers recommendations on ...